Bridging communities in the field of nanomedicine

Halamoda-Kenzaoui, Blanka, Baconnier, Simon, Bastogne, Thierry, Bazile, Didier, Boisseau, Patrick, Borchard, Gerrit, Borgos, Sven Even, Calzolai, Luigi, Cederbrant, Karin, Di Felice, Gabriella
et al (show 15 more authors) (2019) Bridging communities in the field of nanomedicine. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 106. pp. 187-196.

[img] Text
workshop report final draft 28.9.18.docx - Author Accepted Manuscript
Available under License Creative Commons Attribution Non-commercial.

Download (612kB)


An early dialogue between nanomedicine developers and regulatory authorities are of utmost importance to anticipate quality and safety requirements for these innovative health products. In order to stimulate interactions between the various communities involved in a translation of nanomedicines to clinical applications, the European Commission's Joint Research Centre hosted a workshop titled "Bridging communities in the field of Nanomedicine" in Ispra/Italy on the 27th -28th September 2017. Experts from regulatory bodies, research institutions and industry came together to discuss the next generation of nanomedicines and their needs to obtain regulatory approval. The workshop participants came up with recommendations highlighting methodological gaps that should be addressed in ongoing projects addressing the regulatory science of nanomedicines. In addition, individual opinions of experts relevant to progress of the regulatory science in the field of nanomedicine were summarised in the format of a survey.

Item Type: Article
Uncontrolled Keywords: Nanomedicine, workshop, regulatory science, critical quality attributes, immune effects, standardization
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User: Symplectic Admin
Date Deposited: 07 Nov 2022 09:28
Last Modified: 18 Jan 2023 19:48
DOI: 10.1016/j.yrtph.2019.04.011
Related URLs: